Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Ado-trastuzumab emtansine
Trade Name Kadcyla
Synonyms T-DM1|trastuzumab emtansine
Drug Descriptions

Kadcyla (ado-trastuzumab emtansine) is an antibody-drug conjugate (ADC) comprising the ERBB2 (HER2) monoclonal antibody trastuzumab and an anti-tubulin agent, DM1, which results in tumor cell cytotoxicity (PMID: 24887180). Kadcyla (ado-trastuzumab emtansine) is FDA approved for metastatic ERBB2 (HER2)-positive (overexpression or gene amplification) breast cancer patients who have previously received trastuzumab and/or taxane, and for the adjuvant treatment of patients with ERBB2 (HER2)-positive early breast cancer who have residual invasive disease after taxane and trastuzumab-based treatment (FDA.gov).

DrugClasses HER2 (ERBB2) Antibody 73 HER2 (ERBB2) Antibody-Drug Conjugate 27
CAS Registry Number 1018448-65-1
NCIT ID C82492

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Abemaciclib + Ado-trastuzumab emtansine Abemaciclib Ado-trastuzumab emtansine 0 1
Ado-trastuzumab emtansine Ado-trastuzumab emtansine 1 38
Ado-trastuzumab emtansine + Alpelisib Ado-trastuzumab emtansine Alpelisib 0 1
Ado-trastuzumab emtansine + Apitolisib Ado-trastuzumab emtansine Apitolisib 0 0
Ado-trastuzumab emtansine + Atezolizumab Ado-trastuzumab emtansine Atezolizumab 0 3
Ado-trastuzumab emtansine + Bintrafusp alfa + Entinostat + FPV-Brachyury + MVA-BN-Brachyury Ado-trastuzumab emtansine Bintrafusp alfa Entinostat FPV-Brachyury MVA-BN-Brachyury 0 1
Ado-trastuzumab emtansine + Bintrafusp alfa + FPV-Brachyury + MVA-BN-Brachyury Ado-trastuzumab emtansine Bintrafusp alfa FPV-Brachyury MVA-BN-Brachyury 0 1
Ado-trastuzumab emtansine + Capecitabine Ado-trastuzumab emtansine Capecitabine 0 2
Ado-trastuzumab emtansine + Dasatinib Ado-trastuzumab emtansine Dasatinib 0 0
Ado-trastuzumab emtansine + Docetaxel Ado-trastuzumab emtansine Docetaxel 0 1
Ado-trastuzumab emtansine + Docetaxel + Pertuzumab Ado-trastuzumab emtansine Docetaxel Pertuzumab 0 1
Ado-trastuzumab emtansine + DZD1516 Ado-trastuzumab emtansine DZD1516 0 1
Ado-trastuzumab emtansine + ELVN-002 Ado-trastuzumab emtansine ELVN-002 0 1
Ado-trastuzumab emtansine + Everolimus Ado-trastuzumab emtansine Everolimus 0 0
Ado-trastuzumab emtansine + Exemestane + Pyrotinib + Zoledronic acid Ado-trastuzumab emtansine Exemestane Pyrotinib Zoledronic acid 0 0
Ado-trastuzumab emtansine + Inavolisib Ado-trastuzumab emtansine Inavolisib 0 0
Ado-trastuzumab emtansine + Lapatinib Ado-trastuzumab emtansine Lapatinib 0 1
Ado-trastuzumab emtansine + Lapatinib + Nab-paclitaxel Ado-trastuzumab emtansine Lapatinib Nab-paclitaxel 0 1
Ado-trastuzumab emtansine + Letrozole + Palbociclib Ado-trastuzumab emtansine Letrozole Palbociclib 0 1
Ado-trastuzumab emtansine + Mobocertinib Ado-trastuzumab emtansine Mobocertinib 0 0
Ado-trastuzumab emtansine + Neratinib Ado-trastuzumab emtansine Neratinib 0 1
Ado-trastuzumab emtansine + Nivolumab Ado-trastuzumab emtansine Nivolumab 0 0
Ado-trastuzumab emtansine + Osimertinib Ado-trastuzumab emtansine Osimertinib 0 0
Ado-trastuzumab emtansine + Paclitaxel Ado-trastuzumab emtansine Paclitaxel 0 1
Ado-trastuzumab emtansine + Palbociclib Ado-trastuzumab emtansine Palbociclib 0 2
Ado-trastuzumab emtansine + Pembrolizumab Ado-trastuzumab emtansine Pembrolizumab 0 2
Ado-trastuzumab emtansine + Pertuzumab Ado-trastuzumab emtansine Pertuzumab 0 3
Ado-trastuzumab emtansine + Pertuzumab + Trastuzumab + Tucatinib Ado-trastuzumab emtansine Pertuzumab Trastuzumab Tucatinib 0 0
Ado-trastuzumab emtansine + Poziotinib Ado-trastuzumab emtansine Poziotinib 0 1
Ado-trastuzumab emtansine + Sapanisertib Ado-trastuzumab emtansine Sapanisertib 0 0
Ado-trastuzumab emtansine + Sargramostim Ado-trastuzumab emtansine Sargramostim 0 1
Ado-trastuzumab emtansine + Sargramostim + TPIV100 Ado-trastuzumab emtansine Sargramostim TPIV100 0 1
Ado-trastuzumab emtansine + TAEK-VAC-HerBy Ado-trastuzumab emtansine TAEK-VAC-HerBy 0 1
Ado-trastuzumab emtansine + Temozolomide Ado-trastuzumab emtansine Temozolomide 0 1
Ado-trastuzumab emtansine + Trastuzumab Ado-trastuzumab emtansine Trastuzumab 0 3
Ado-trastuzumab emtansine + Tucatinib Ado-trastuzumab emtansine Tucatinib 0 6
Ado-trastuzumab emtansine + Utomilumab Ado-trastuzumab emtansine Utomilumab 0 1
Ado-trastuzumab emtansine + Venetoclax Ado-trastuzumab emtansine Venetoclax 0 1
Ado-trastuzumab emtansine + Vinorelbine Ado-trastuzumab emtansine Vinorelbine 0 1
Ado-trastuzumab emtansine + ZN-A-1041 Ado-trastuzumab emtansine ZN-A-1041 0 1


Additional content available in CKB BOOST